Evidence, not personal-use guidance
This page explains research terminology and documentation. It does not provide medical advice, dosing, injection, administration or a recommendation to obtain or use any substance.
What is SS-31 / Elamipretide?
SS-31, also known as elamipretide in clinical-development contexts, is a mitochondria-targeting tetrapeptide studied in bioenergetic and disease models.
Search results often combine research papers, supplier descriptions and personal claims. Those sources answer different questions. A paper can describe a mechanism or study outcome; only a batch-specific analytical record can describe the tested sample.
Identity and naming
SS-31 and elamipretide may refer to the same core sequence, but a record should still state stereochemistry, terminal groups, salt and formulation. Tetrapeptides can contain stereochemical variants with the same nominal mass.
Useful records state the exact material, expected molecular characteristics, batch code, sample identifier and form. See peptide sequence and molecular weight for why a familiar name is not enough.
What the research base shows
The research base spans biochemical studies, animal models and human clinical trials in selected conditions. Trial outcomes must be read endpoint by endpoint and cannot be converted into general claims about energy or ageing.
Evidence should be sorted by level: biochemical or cell studies, animal models, observational human data, controlled trials and regulatory evidence. A result at one level should not be silently rewritten as a conclusion at another.
Analytical and COA questions
Mass alone may not distinguish stereochemical or sequence variants. Chromatography with suitable reference material and method selectivity is important alongside content and impurity profiling.
- Does the report name this exact molecular form?
- Does the sample or batch code match the container?
- Are identity, peak-area purity and quantitative content reported separately?
- Can the laboratory and report number be independently traced?
Use the field-by-field COA guide before relying on a headline percentage.
What this page cannot establish
It cannot establish that any commercial material is genuine, sterile, safe, legally supplied or suitable for a particular purpose. Regulatory status and authorised uses can change and vary by country; consult the MHRA Products registry and other relevant official sources.
Frequently asked questions
Are SS-31 and elamipretide the same?
The names are commonly linked to the same core peptide, but the exact pharmaceutical or research form should be stated.
Why is mass alone limited?
Different isomers or sequences can share nominal mass, so orthogonal identity evidence may be needed.
Related external reading:
- third-party peptide testingexternal · supplier educational page
External links are editorial references, not endorsements.
Research sources
- PubMed literature search: SS-31 / Elamipretide.
- ClinicalTrials.gov search: SS-31 / Elamipretide.
- IUPAC peptide terminology.
- ICH Q2(R2): analytical procedure validation.
Search links are provided because the literature and regulatory status can change. Sources were checked on 19 September 2026.